This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Apr 19;98(8):506-7.

doi: 10.1093/jnci/djj155.

Assessing risk: does this patient have prostate cancer?

H Ballentine Carter

PMID: 16622114
DOI: 10.1093/jnci/djj155

Editorial

Assessing risk: does this patient have prostate cancer?

H Ballentine Carter. J Natl Cancer Inst. 2006.

. 2006 Apr 19;98(8):506-7.

doi: 10.1093/jnci/djj155.

Author

H Ballentine Carter

PMID: 16622114
DOI: 10.1093/jnci/djj155

No abstract available

PubMed Disclaimer

Comment on

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr. Thompson IM, et al. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131. J Natl Cancer Inst. 2006. PMID: 16622122

Similar articles

[Detection of prostate cancer: yes or no?].
Van Cangh PJ. Van Cangh PJ. Bull Mem Acad R Med Belg. 2006;161(3-4):159-69. Bull Mem Acad R Med Belg. 2006. PMID: 17172224 Review. French. No abstract available.
Screening for prostate cancer - will we ever know?
Adolfsson J. Adolfsson J. Acta Oncol. 2010 Apr;49(3):275-7. doi: 10.3109/02841861003696803. Acta Oncol. 2010. PMID: 20397764 No abstract available.
Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ, Mulley AJ Jr. Barry MJ, et al. J Natl Cancer Inst. 2009 Mar 18;101(6):362-3. doi: 10.1093/jnci/djp028. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276451 No abstract available.
Prostate cancer: is the PSA test the answer?
Berlin B. Berlin B. N J Med. 1998 Mar;95(3):53-5. N J Med. 1998. PMID: 16013148 Review. No abstract available.
Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Welch HG, et al. J Natl Cancer Inst. 2007 Sep 19;99(18):1395-400. doi: 10.1093/jnci/djm119. Epub 2007 Sep 11. J Natl Cancer Inst. 2007. PMID: 17848671

See all similar articles

Cited by

Prostate cancer regulatory networks.
Altieri DC, Languino LR, Lian JB, Stein JL, Leav I, van Wijnen AJ, Jiang Z, Stein GS. Altieri DC, et al. J Cell Biochem. 2009 Aug 1;107(5):845-52. doi: 10.1002/jcb.22162. J Cell Biochem. 2009. PMID: 19492418 Free PMC article. Review.
The Risk Factors and Screening Uptake for Prostate Cancer: A Scoping Review.
Mumuni S, O'Donnell C, Doody O. Mumuni S, et al. Healthcare (Basel). 2023 Oct 20;11(20):2780. doi: 10.3390/healthcare11202780. Healthcare (Basel). 2023. PMID: 37893854 Free PMC article.
The evolving biology and treatment of prostate cancer.
Taichman RS, Loberg RD, Mehra R, Pienta KJ. Taichman RS, et al. J Clin Invest. 2007 Sep;117(9):2351-61. doi: 10.1172/JCI31791. J Clin Invest. 2007. PMID: 17786228 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information